Melinta Therapeutics announces FDA approval of REZZAYO™
Congratulations to Melinta Therapeutics for their FDA Approval of REZZAYO™ for the Treatment of...
read Details![Melinta Therapeutics announces FDA approval of REZZAYO™](https://www.modality-solutions.com/wp-content/uploads/2023/12/Modality-Resource-Featured-Images-13.png)
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for the treatment of sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT).
We are proud to have contributed to Vertex’s cold chain with full transport validation support, including transport simulation testing using Modality Solutions’ Advantage Transport Simulation Laboratory™.
Congratulations to Melinta Therapeutics for their FDA Approval of REZZAYO™ for the Treatment of...
read DetailsCongratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...
read DetailsCongratulations to Incyte on their FDA approval for Zynyz™, a treatment for adults with metastatic...
read Details